Combinations of cis-4-hydroxy-L-proline and N-methyl-cis-4-hydroxy-L-proline, especially for use as therapeutics in the treatment of cancer

摘要

PCT No. PCT/DE97/00486 Sec. 371 Date Sep. 9, 1998 Sec. 102(e) Date Sep. 9, 1998 PCT Filed Mar. 11, 1997 PCT Pub. No. WO97/33578 PCT Pub. Date Sep. 18, 1997The disclosure relates to a combination of cis-4-hydroxy-L-proline and n-methyl-cis-4-hydroxy-L-proline for use as a therapeutic agent, in particular in cancer treatment. Also disclosed is the use of the individual substances for treating hormone-sensitive prostate cancer.